The therapeutic effect of the neuropetide hormone somatostatin on Schistosoma mansoni caused liver fibrosis

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Chatterjee, Shyama ^a   Vrolix, Gunther ^a   Depoortere, Inge ^b   Peeters, Theo ^b   Van Marck, Eric ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Laboratory of Gastrointestinal Hormones   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; HYDROXYPROLINE; NEUROPEPTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATINE UCB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CERCARIA; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG MECHANISM; FROZEN SECTION; LD 50; LIVER; LIVER FIBROSIS; LIVER FUNCTION; LIVER GRANULOMA; LIVER HISTOLOGY; MALE; MOUSE; NONHUMAN; OUTBRED STRAIN; PARASITE IDENTIFICATION; RADIOIMMUNOASSAY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SOMATOSTATIN BLOOD LEVEL; SPECTROPHOTOMETRY; SPLEEN; STATISTICAL ANALYSIS; TISSUE LEVEL; WEIGHT REDUCTION; ANIMAL; BLOOD; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; LIVER CIRRHOSIS; ORGAN SIZE; PARASITOLOGY; PATHOLOGY; SCHISTOSOMIASIS MANSONI; TIME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; LIVER; LIVER CIRRHOSIS; MALE; MICE; ORGAN SIZE; SCHISTOSOMIASIS MANSONI; SOMATOSTATIN; SPLEEN; TIME FACTORS;

EID: 24944437871     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-45     Document Type: Article

References (20)

1. Chatterjee S, Mbaye A, Alfidja AT, Weyler J, Scott JT, Van Damme P, Van De Vijver K, Deelder A, Van Marck EAE: Circulating levels of the neuropeptide hormone somatostatin may determine hepatic fibrosis in Schistosoma mansoni infections. Acta Trop 2004, 90: 191-203.
2. Avgerinos A, Nevens F, Raptis S, Fevery J: Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European acute bleeding oesophageal variceal episodes (ABOVE) randomized trial. Lancet 1997, 350: 1495-1499.
3. Lin HJ, Perng CL, Lee FY, Lee CH, Lee SD: Clinical courses and predictors for rebleeding in patients with peptic ulcers and non-bleeding visible vessels: a prospective study. Gut 1994, 35: 1389-1393.
4. Bordas JM, Toledo-Pimentel V, Llach J, Elena M, Mondelo F, Gines A, Teres J: Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastroint Endosc 1988, 47, 230-234.
5. Borda F, Jimenez FJ, Villa J: Cost-effectiveness study on the use of somatostatin for reduction of acute pancreatitis after ERCP. Gastroentero Hepatol 2001, 24: 292-296.
6. Cicero GF, Laugier R, Sahel J, Manganaro M, Sarles H: Effects of somatostatin on clinical, biochemical and morphological changes following ERCP. Int J Gastroenterol 1985, 17: 265-268.
7. Cheever AW: Quantitative comparison of the intensity of Schistosoma mansoni infection in man and experimental animals. Trans R Soc Trop Med 1969, 63: 781-795.
8. Andrade ZA, Grimaud J-A: Morphology of chronic collagen resorption (a study on the late stages of schistosomal granuloma involution. Am J Path 1988, 132: 389-39.
9. Grimaud J-A: Cell-matrix interactions in schistosomal portal fibrosis: a dynamic event. Mem Inst Oswaldo Cruz 1987, 82: 55-65.
10. Da Silva LC, Mourao PA, Borojevic R: Patterns of sulfated glycosaminoglycan synthesis and accumulation in hepatic granulomas induced by Schistosomal infection. Exp Mol Pathol 1989, 50: 411-420.
11. Van Marck EA, Stocker S, Grimaud JA, Kestens L, Gigase PL, Deelder AM: The implantation of sepharose beads in mouse livers as an aid in the study of hepatic schistosomal fibrosis. Experientia 1980, 36:1116-1118.
12. Reynaert H, Vaeyens F, Rombouts K, Chatterjee N, Urbain D, Geerts A: Effect of somatostatin-14 on extracellular matrix expression by activated rat hepatic stellate cells. J Hepatol 2001, 34: 6
13. Chatterjee S, Mbaye A, De Man J, Van Marck E: Does the neuropeptide somatostatin have a therapeutic role in schistosomiasis? Trends Parasitol 2002, 18: 295-298.
14. Van Marck EAE: The glomerulopathy associated with Schistosoma mansoni infection. An experimental study in the mouse. Acta Leidensia 1983, 50.
15. Bergman I, Loxley R: Two improved and simplified methods for spectrophotometric determination of hydroxyproline. Analyt Chem 1963, 35: 1961-1965.
16. Cheever AW, Duvall RH, Hallack Jr TA, Minker RG, Malley JD, Malley KG: Variations of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am J Trop Med Hyg 1987, 37: 85-97.
17. Peters GE: Distribution and metabolism of exogenous somatostatin in the rat. Reg Pept 1982, 3: 361-369.
18. Peeters TL, Janssens J, Vantrappen GR: Somatostatin and the interdigestive migrating motor complex in man. Reg Pept 1983, 5: 209-217.
19. Nishimura MO, Asahi M, Hayashi M, Takazono I, Tanaka Y, Kohda H, Urabe H: Extracellular matrix in hepatic granulomas of mice infected with Schistosoma mansoni (qualitative and quantitative analysis) Arch Path Lab Med 1985, 109: 813-818.
20. Mansy SS, Yehia HA, Hassan MM, Hassan EA, Youssef MM, Hadi AA, Mackenzie CD: Effect of octreotide on the pathology of hepatic schistosomiasis. Arzneimittelforschung 1998, 48: 855-861.